Boothbay Fund Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.68M	Sell	529,503 -5,004	-0.9%	-$58.1K	0.18%	195
2025 Q4	$5.14M	Sell	534,507 -5,135	-1%	-$49.2K	0.13%	284
2025 Q3	$5.07M	Buy	539,642 +10,139	+2%	+$96.8K	0.13%	314
2025 Q2	$5.6M	Hold	529,503	–	–	0.17%	266
2025 Q1	$7.96M	Hold	529,503	–	–	0.27%	122
2024 Q4	$8.72M	Buy	529,503 +25,665	+5%	+$506K	0.26%	125
2024 Q3	$12.4M	Buy	503,838 +1,888	+0.4%	+$48.9K	0.37%	56
2024 Q2	$12.7M	Sell	501,950 -224	-0%	-$5.8K	0.39%	47
2024 Q1	$12.8M	Sell	502,174 -7,348	-1%	-$178K	0.35%	55
2023 Q4	$11.5M	Sell	509,522 -108,080	-17%	-$2.24M	0.39%	52
2023 Q3	$11.5M	Buy	617,602 +128,975	+26%	+$2.67M	0.36%	65
2023 Q2	$12.7M	Buy	488,627 +1,630	+0.3%	+$43.6K	0.39%	46
2023 Q1	$14M	Buy	486,997 +119,487	+33%	+$3.56M	0.36%	42
2022 Q4	$10.9M	Buy	367,510 +197,510	+116%	+$5.62M	0.33%	56
2022 Q3	$4.05M	Buy	+170,000	New	+$3.91M	0.12%	256
2016 Q4	–	Sell	-4,298	Closed	-$206K	–	745
2016 Q3	$206K	Buy	+4,298	New	+$212K	0.07%	549